COPN.SW
Price:
$65.6
Market Cap:
$1.12B
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancer...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-03-12
Stock Exchange
SIX
Ticker
COPN.SW
According to Cosmo Pharmaceuticals N.V.’s latest financial reports and current stock price. The company's current PE Ratio is 16.20. This represents a change of -161.81% compared to the average of -26.21 of the last 4 quarters.
The mean historical PE Ratio of Cosmo Pharmaceuticals N.V. over the last ten years is -23.32. The current 16.20 PE Ratio has changed -7045.76% with respect to the historical average. Over the past ten years (40 quarters), COPN.SW's PE Ratio was at its highest in in the March 2023 quarter at 310.95. The PE Ratio was at its lowest in in the September 2014 quarter at -263.63.
Average
-23.32
Median
-16.86
Minimum
-178.94
Maximum
115.10
Discovering the peaks and valleys of Cosmo Pharmaceuticals N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual PE Ratio = 115.10
Minimum Annual Increase = -403.62%
Minimum Annual PE Ratio = -178.94
Year | PE Ratio | Change |
---|---|---|
2023 | -178.94 | -403.62% |
2022 | 58.94 | 19.99% |
2021 | 49.12 | -134.12% |
2020 | -143.96 | 241.20% |
2019 | -42.19 | -36.61% |
2018 | -66.56 | 16.67% |
2017 | -57.05 | -149.56% |
2016 | 115.10 | 1.26% |
2015 | 8.46 | -64.51% |
2014 | 23.84 | 65.82% |
The current PE Ratio of Cosmo Pharmaceuticals N.V. (COPN.SW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-23.63
5-year avg
-51.41
10-year avg
-23.32
Cosmo Pharmaceuticals N.V.’s PE Ratio is greater than Basilea Pharmaceutica AG (-843.72), greater than Newron Pharmaceuticals S.p.A. (-8.28), greater than Santhera Pharmaceuticals Holding AG (0.96), greater than Evolva Holding SA (-0.33), greater than Addex Therapeutics Ltd (1.83),
Company | PE Ratio | Market cap |
---|---|---|
-843.72 | $518.79M | |
-8.28 | $152.34M | |
0.96 | $104.84M | |
-0.33 | $6.76M | |
1.83 | $15.30M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cosmo Pharmaceuticals N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cosmo Pharmaceuticals N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cosmo Pharmaceuticals N.V.'s PE Ratio?
How is the PE Ratio calculated for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the highest PE Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the 3-year average PE Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
What is the 5-year average PE Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW)?
How does the current PE Ratio for Cosmo Pharmaceuticals N.V. (COPN.SW) compare to its historical average?